Pharmaceutical Resource Technology, Inc.

Earlier extract: THE OFFERING TO PROCEED. 3 PHARMACEUTICAL RESOURCE TECHNOLOGY, INC. OFFERING 100,000,000 Shares of Common Stock at $0.50 / share Price Per Share Underwriting Discounts and commissions Estimated Expenses Total Proceeds $0.50 $0.00 $92,000 $49,908,000 The Compan

Later extract: THE OFFERING TO PROCEED. 3 PHARMACEUTICAL RESOURCE TECHNOLOGY, INC. OFFERING 100,000,000 Shares of Common Stock at $0.50 / share Primary Offering: We are offering up to 100,000,000 shares of our common stock at a fixed price of $0.50 per share. Resale Offering

Earlier extract: TABLE OF CONTENTS PART I — PROSPECTUS 1. PROSPECTUS SUMMARY 6 2. RISK FACTORS 12 3. USE OF PROCEEDS 20 4. DILUTION 22 5. CAPITALIZATION 26 6. PLAN OF DISTRIBUTION 30 7. DETERMINATION OF OFFERING PRICE 33 8. DESCRIPTION OF SECURITIES 34 9. INTERESTS OF NA

Later extract: ns Estimated Expenses Total Proceeds $0.50 $0.00 $92,000 $49,908,000 We estimate that the net proceeds from this offering, assuming all shares are sold, will be approximately $49,908,000. We intend to use these proceeds primarily for expansion of our manufactu

Earlier extract: shares of our common stock directly to investors without the involvement of a traditional underwriter. There is no minimum number of shares required to be sold in this offering, and we may sell any number of shares up to the maximum amount being offered. We ar

Later extract: connection with the sale of shares in this offering. We may, however, engage one or more underwriters or placement agents in the future, in which case customary underwriting discounts or commissions may be paid. There is no minimum number of shares that must b